+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Saudi Arabia - Healthcare (Pharmaceuticals and Medical Devices), Regulatory and Reimbursement Landscape

  • PDF Icon

    Report

  • 171 Pages
  • February 2022
  • Region: Saudi Arabia
  • GlobalData
  • ID: 2881940
Description Jump to:
the publisher, has released its latest report “Saudi Arabia:Healthcare (Pharmaceuticals and Medical Devices), Regulatory and Reimbursement Landscape”. The report is an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape in Saudi Arabia. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory and reimbursement landscape, and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by the publisher’s team of industry experts.

Saudi Arabia’s pharmaceutical market has high potential and is one of the fastest developing pharmaceutical markets in Asia. The rise in communicable and non-communicable diseases, and government initiatives such as National Drug Policy intended to drive the growth of the Saudi Arabia’s pharmaceutical market. While inadequate power and water supply, dysfunctional transport system, and under-utilized manufacturing capacity, along with counterfeiting drugs are hindering the development of the healthcare market. Saudi Arabia’s pharmaceutical market, based on pharmaceutical production value, $6.6 billion in 2013 is expected to increase to $10.2 billion in 2020 at a Compound Annual Growth Rate (CAGR) of 6.4%. It is forecast to reach about $14.8 billion in 2026. The medical devices market of Saudi Arabia was valued at $3.6 billion in 2016, which is expected to increase to $4.8 billion in 2020 at a CAGR of 6.0%. The medical device market is expected to grow at a CAGR of 4% from $5 billion in 2021 to $6.1 billion in 2027.

Scope


The report provides information on the healthcare, regulatory, and reimbursement landscape in Saudi Arabia, and includes:

  • An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers.
  • Profiles and SWOT analyses of the major players in the pharmaceutical market: Novartis, GlaxoSmithKline, Pfizer, Tabuk, and SPIMACO.
  • Profiles and SWOT analyses of the major players in the medical device market: Fujitsu, Medtronic, AstraZeneca, Kimberly Clark and GE Healthcare.
  • An insightful review of the COVID-19 epidemiology, COVID-19 impact and developments in healthcare market, HealthTech landscape, reimbursement, and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices.
  • Detailed analysis of the country’s healthcare policy highlights, demographics, healthcare infrastructure and healthcare expenditure.
  • An overview of the opportunities for and challenges to growth in the Saudi Arabian healthcare market.

Reasons to Buy


This report will enhance your decision-making capability by allowing you to:

  • Develop business strategies by understanding the trends shaping and driving Saudi Arabian healthcare market
  • Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact Saudi Arabian healthcare market in the future
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance
  • Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership

Table of Contents

1. Table of Contents
1.1 List of Figures
1.2 List of Tables
2. Executive Summary
2.1 Executive Summary
2.2 Key Highlights: Facts about the Saudi Arabia Healthcare Market
2.3 Key Highlights: Healthcare Startups in Saudi Arabia
2.4 Key Events: Saudi Arabia Pharmaceutical News, 2015-2021
2.5 Key Events: Saudi Arabia Pharmaceutical Market
2.6 Key Events: M&As, VC & PE Deals, Global Pharmaceutical Market, 2020-2021
2.7 Key Events: Mergers and Acquisitions
2.8 Country Profile, Saudi Arabia, 2021
3. Overview of Pharmaceutical Market
3.1 Pharmaceutical Market - Overview
3.2 Pharmaceutical Market - Exports
3.3 Pharmaceutical Market - Imports
3.4 Pharmaceutical Market - Supply Channels, Saudi Arabia
3.5 Pharmaceutical Market - Market Segments
3.6 COVID-19 Epidemiology, Saudi Arabia
3.7 COVID-19 Impact and Developments, Saudi Arabia
3.8 COVID-19 Impact and Developments in the Healthcare Market, Saudi Arabia
3.9 COVID-19 Clinical Trials Landscape, Saudi Arabia
3.10 Pharmaceutical Market - Major Players
4. Overview of Medical Devices Market
4.1 Medical Device Market - Overview
4.2 Medical Devices Market - Major Players
5. Pharmaceutical and Medical Devices Market - Drivers and Barriers
5.1 Drivers
5.2 Barriers
6. Deal Analysis
6.1 Deal Analysis: Pharmaceutical Market, Saudi Arabia, 2019-2021
6.2 Deal Analysis: Medical Device Market, Saudi Arabia, 2019-2021
7. HealthTech Landscape
7.1 HealthTech Landscape, Saudi Arabia
7.2 HealthTech Deals Landscape, Saudi Arabia
7.3 Key HealthTech Deals, Saudi Arabia
7.4 Adoption of Technology in Healthcare, Saudi Arabia
7.5 Digital Statistics, Saudi Arabia
7.6 Digital Regulations, Saudi Arabia
7.7 HealthTech Landscape: Benefits and Risks, Saudi Arabia
8. Market Access
8.1 Overview of Healthcare System, Saudi Arabia
8.2 Reimbursement Process, Saudi Arabia
8.3 Overview of Insurance Providers, Saudi Arabia
8.4 Out-of-Pocket Spending and Pharmaceutical Price Index, Saudi Arabia
8.5 Pricing Policies, Saudi Arabia
8.6 Regulatory Landscape, Saudi Arabia
9. Country Healthcare Landscape
9.1 Saudi Arabian Healthcare Policy Highlights
9.2 Healthcare Facilities, Saudi Arabia
9.3 Healthcare Parameters, Saudi Arabia
9.4 Life Expectancy and Immunization Rate, Saudi Arabia
9.5 Environmental Health, Saudi Arabia
9.6 Healthcare Personnel, Saudi Arabia
9.7 Disease Burden, Saudi Arabia
9.8 Healthcare Expenditure, Saudi Arabia
10 Trade Associations, Saudi Arabia11 Trade Fairs, Saudi Arabia12 Opportunities and Challenges13 Appendix
List of Tables
Table 1: Approved biosimilars, Saudi Arabia, 2020
Table 2: Opportunities in pharmaceutical and biotech clusters, Saudi Arabia, 2021
Table 3: Top 10 selling biopharma drugs, Saudi Arabia, 2021
Table 4: COVID-19 indicators, Global and Saudi Arabia, 2022
Table 5: Available COVID-19 IVD products, Saudi Arabia, 2020-2021
Table 6: Pipeline COVID-19 IVD products, Saudi Arabia, 2020-2021
Table 7: Authorized COVID-19 vaccines, Saudi Arabia, 2020-2021
Table 8: Medical devices market, major segments ($M), Saudi Arabia, 2020
Table 9: Health insurance market, market share (%), Saudi Arabia, 2021
Table 10: Pharmaceutical approval timelines, Saudi Arabia, 2019
Table 11: MDMA evaluation fees, Saudi Arabia, 2021
Table 12: License or renewal fee ($), Saudi Arabia, 2019
Table 13: Profit margin (%), Saudi Arabia, 2019
Table 14: Customs ports, Saudi Arabia, 2021
Table 15: Patent fees ($), Saudi Arabia, 2021
Table 16: Trademark fees ($), Saudi Arabia, 2019
Table 17: Label of a pharmaceutical product, Saudi Arabia, 2021
Table 18: Minimum particulars to appear on blisters or strips, Saudi Arabia, 2021
Table 19: Minimum particulars to appear on small immediate packaging, Saudi Arabia, 2021
Table 20: Label of a pharmaceutical product, Saudi Arabia, 2021
Table 21: Recommendations for primary packaging, Saudi Arabia
Table 22: Recommendations for secondary packaging, Saudi Arabia
Table 23: Trade Fairs, Saudi Arabia, 2022
List of Figures
Figure 1: Pharmaceutical market, revenue ($B and SARB), Saudi Arabia, 2013-2020
Figure 2: Medical devices market, revenue ($B), Saudi Arabia, 2016-2021
Figure 3: Healthcare startups in Saudi Arabia, 2022
Figure 4: Country profile, Saudi Arabia, 2022
Figure 5: Pharmaceutical market, revenue ($B), Saudi Arabia, 2013-2020
Figure 6: Pharmaceutical market, revenue forecast ($B), Saudi Arabia, 2021-2026
Figure 7: Pharmaceutical exports ($M), South Arabia, 2011-2020
Figure 8: Top export partners, Saudi Arabia, 2020
Figure 9: Pharmaceutical imports ($B), Saudi Arabia, 2011-2020
Figure 10: Top import partners, Saudi Arabia, 2020
Figure 11: Pharmaceutical supply chain, Saudi Arabia, 2022
Figure 12: Drug track and trace system, Saudi Arabia, 2022
Figure 13: Innovation centers, Saudi Arabia, 2021
Figure 14: Major OTC drug classes (share %), Saudi Arabia, 2018
Figure 15: COVID-19 (number of cases), Saudi Arabia, 2020-2022
Figure 16: COVID-19 (number of deaths), Saudi Arabia, 2020-2022
Figure 17: COVID-19-related travel restrictions, Saudi Arabia, 2020-2021
Figure 18: COVID-19 fiscal stimulus timeline, Saudi Arabia, 2020-2021
Figure 19: COVID-19 vaccine dose administration, number of vaccine doses administered, Saudi Arabia, 2021-2022
Figure 20: COVID-19 clinical trials sponsors by count, Saudi Arabia, 2020-22
Figure 21: COVID-19 clinical trials count by phase, Saudi Arabia, 2020-2022
Figure 22: COVID-19 clinical trials count by trial status, Saudi Arabia, 2020-2022
Figure 23: Medical devices market, revenue ($B), Saudi Arabia, 2016-2021
Figure 24: Medical devices market, revenue forecast ($B), Saudi Arabia, 2022-2027
Figure 25: Medical devices market, major segments (%), Saudi Arabia, 2020
Figure 26: Hospital supplies market, revenue ($B), Saudi Arabia, 2017-2025
Figure 27: General surgery market, revenue ($M), Saudi Arabia, 2017-2025
Figure 28: Orthopedic devices, revenue ($M), Saudi Arabia, 2017-2025
Figure 29: Cardiovascular devices, revenue ($M), Saudi Arabia, 2017-2025
Figure 30: Anesthesia and respiratory devices, revenue ($M), Saudi Arabia, 2017-2025
Figure 31: Diagnostic market, revenue ($M), Saudi Arabia, 2016-2021
Figure 32: Diagnostic market, revenue ($M), Saudi Arabia, 2022-2027
Figure 33: Medical devices market, revenue ($B) of major companies, Saudi Arabia, 2020
Figure 34: Deals value and deal count, pharmaceutical market, Saudi Arabia, 2019-2022
Figure 35: Deals value and deal count, subtypes, pharmaceutical market, Saudi Arabia, 2019-2022
Figure 36: Deals value and deal count, quarterly, pharmaceutical market, Saudi Arabia, 2019-2022
Figure 37: Top therapy areas by deal value ($M), pharmaceutical market, Saudi Arabia, 2019-2022
Figure 38: Top therapy areas by deal count, pharmaceutical market, Saudi Arabia, 2019-2022
Figure 39: M&A deals by quarter, pharmaceutical market, Saudi Arabia, 2019-2022 (by value and by number)
Figure 40: Deals value and deal count, medical devices market, Saudi Arabia, 2019-2022
Figure 41: Deals value and deal count, subtypes, medical devices market, Saudi Arabia, 2019-2022
Figure 42: Deals value and deal count, quarterly, medical devices market, Saudi Arabia, 2019-2021
Figure 43: Top equipment sectors by deal value ($M), medical devices market, Saudi Arabia, 2019-2022
Figure 44: Top equipment sectors by deal count, medical devices market, Saudi Arabia, 2019-2022
Figure 45: M&A deals by quarter, medical devices market, Saudi Arabia, 2019-2022 (by value and by number)
Figure 46: e-health strategy supporting MOH goals, Saudi Arabia, 2021
Figure 47: Digital health strategy, mission and vision, Saudi Arabia, 2021
Figure 48: Key objectives, digital health strategy, Saudi Arabia, 2021
Figure 49: Organizational chart, digital health governance, Saudi Arabia, 2021
Figure 50: Deals value ($M), healthTech, Saudi Arabia, 2019-2022
Figure 51: Deal count (number of deals), healthtech, Saudi Arabia, 2019-2022
Figure 52: Digital technology, Saudi Arabia, 2022
Figure 53: Structural overview of healthcare sector, Saudi Arabia, 2021
Figure 54: Organizational chart of ministry of health, Saudi Arabia, 2021
Figure 55: National Healthcare Transformation Program (NHTP), Saudi Arabia, 2021
Figure 56: SFDA Strategic Plan (2018-2022) specifications, Saudi Arabia, 2021
Figure 57: Formulary additions, Saudi Arabia, 2021
Figure 58: Drug approval process, Saudi Arabia, 2021
Figure 59: National insurance system of GOSI, Saudi Arabia, 2021
Figure 60: Out-of-Pocket spending ($ per capita), Saudi Arabia, 2011-2021
Figure 61: Annual rate of change (%), health price index, Saudi Arabia, 2015-2021
Figure 62: SFDA, organizational structure, Saudi Arabia, 2021
Figure 63: MAA submission process, Saudi Arabia, 2021
Figure 64: Drug licensing, Saudi Arabia, 2021
Figure 65: Drug licensing renewal, Saudi Arabia, 2021
Figure 66: Process for designating a biosimilar for priority review, Saudi Arabia, 2021
Figure 67: Process for designating a novel drug for priority review, Saudi Arabia, 2021
Figure 68: Patent application process, Saudi Arabia, 2021
Figure 69: Pharmaceutical clinical trials count by trial status, Saudi Arabia, 2019-2022
Figure 70: Pharmaceutical clinical trials count by phase, Saudi Arabia, 2019-2022
Figure 71: Pharmaceutical clinical trials count by indication, Saudi Arabia, 2019-2022
Figure 72: Top five pharmaceutical clinical trials sponsors by count, Saudi Arabia, 2019-2022
Figure 73: Medical devices clinical trials count by trial status, Saudi Arabia, 2019-2022
Figure 74: Medical devices clinical trials count by indication, Saudi Arabia, 2019-2022
Figure 75: Medical devices clinical trials count by device category, Saudi Arabia, 2019-2022
Figure 76: Top five medical devices clinical trials sponsors by count, Saudi Arabia, 2019-2022
Figure 77: Number of hospitals (per 10,000 population), Saudi Arabia, 2016-2020
Figure 78: Hospital beds (per 1,000 population), Saudi Arabia, 2011-2017

Related Topics

Related Reports

Middle East & Africa TSM (Testing, Screening & Monitoring) Devices Market Outlook, 2028 - Product Image

Middle East & Africa TSM (Testing, Screening & Monitoring) Devices Market Outlook, 2028

  • Report
  • 74 Pages
  • Africa, Middle East
From
Intravenous (IV) Equipment Market Outlook, 2028 - Product Image

Intravenous (IV) Equipment Market Outlook, 2028

  • Report
  • 173 Pages
  • Global
From
Saudi Arabia Hospital Supplies - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Image

Saudi Arabia Hospital Supplies - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • 90 Pages
  • Saudi Arabia
From
MEA Medical Devices Packaging - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029) - Product Image

MEA Medical Devices Packaging - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029)

  • Report
  • 101 Pages
  • Africa, Middle East
From
Saudi Arabia Wearable Medical Devices Market Size, Share & Trends Analysis Report by Product (Diagnostic, Therapeutic), Site, Application, Grade Type, Distribution Channel, and Segment Forecasts, 2024-2030 - Product Image

Saudi Arabia Wearable Medical Devices Market Size, Share & Trends Analysis Report by Product (Diagnostic, Therapeutic), Site, Application, Grade Type, Distribution Channel, and Segment Forecasts, 2024-2030

  • Report
  • 80 Pages
  • Saudi Arabia
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.